Biological Therapy for Ulcerative Colitis: What is after Anti-TNF

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|10|1433-1439

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.10, 2011-09, pp. : 1433-1439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Anti-TNF Therapy Reduce the Requirement for Surgery in Ulcerative Colitis? A Systematic Review

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-01 ,pp. : 1440-1447

Bentham Science Publishers

Access to resources Recommend Favorite

Warning: anti-TNF therapy might cause tuberculosis

By O'Neill L.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 9-9

Elsevier

Access to resources Recommend Favorite

Anti-TNF- therapy successful in refractory polymyositis

By  

Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Anti-Tumour Necrosis Factor Therapy for Ulcerative Colitis: Evidence to Date

By Thukral Chandrashekhar   Cheifetz Adam   Peppercorn Mark A.  

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2059-2065

Adis International

Access to resources Recommend Favorite

Current therapy of ulcerative colitis in children

By Bremner Alan Ronald   Griffiths David Mervyn   Beattie Robert Mark  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 37-53

Informa Healthcare

Access to resources Recommend Favorite